eFFECTOR Therapeutics Inc - Warrants (26/08/2026)
EFTRW
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.6K
Close$
$-2.09
348383.3% downside
Current Fair Value
348383.3% downsideOvervalued by 348383.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1,602.00 |
|---|---|
| Enterprise Value | $-471,066.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-16.37 |
| Beta | 0.99 |
| Outstanding Shares | 2,669,960 |
Return
| Return on Equity | 2.37% |
|---|---|
| Return on Assets | 2.29% |
| Return on Invested Capital | -0.27% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -507.21 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About eFFECTOR Therapeutics Inc
CEO: Steve Worland Locust Walk Acquisition Corp. is a blank-check company formed for the purpose of acquiring or merging with one or more businesses,